Morrow JD - Search Results

1

Elevated CSF prostaglandin E2 levels in patients with probable AD.

Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ 2nd, Morrow JD. Montine TJ, et al. Among authors: morrow jd. Neurology. 1999 Oct 22;53(7):1495-8. doi: 10.1212/wnl.53.7.1495. Neurology. 1999. PMID: 10534257

2

Lipid peroxidation in aging brain and Alzheimer's disease.

Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: morrow jd. Free Radic Biol Med. 2002 Sep 1;33(5):620-6. doi: 10.1016/s0891-5849(02)00807-9. Free Radic Biol Med. 2002. PMID: 12208348 Review.

3

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Among authors: morrow jd. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

4

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

Roberts LJ 2nd, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, Dettbarn WD, Morrow JD. Roberts LJ 2nd, et al. Among authors: morrow jd. J Biol Chem. 1998 May 29;273(22):13605-12. doi: 10.1074/jbc.273.22.13605. J Biol Chem. 1998. PMID: 9593698 Free article.

5

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

Montine TJ, Markesbery WR, Morrow JD, Roberts LJ 2nd. Montine TJ, et al. Among authors: morrow jd. Ann Neurol. 1998 Sep;44(3):410-3. doi: 10.1002/ana.410440322. Ann Neurol. 1998. PMID: 9749613

6

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: morrow jd. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

7

Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease.

Montine TJ, Beal MF, Robertson D, Cudkowicz ME, Biaggioni I, O'Donnell H, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Among authors: morrow jd. Neurology. 1999 Mar 23;52(5):1104-5. doi: 10.1212/wnl.52.5.1104. Neurology. 1999. PMID: 10102447 No abstract available.

8

Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice.

Montine TJ, Montine KS, Olson SJ, Graham DG, Roberts LJ 2nd, Morrow JD, Linton MF, Fazio S, Swift LL. Montine TJ, et al. Among authors: morrow jd. Exp Neurol. 1999 Jul;158(1):234-41. doi: 10.1006/exnr.1999.7067. Exp Neurol. 1999. PMID: 10448437

9

Divergence of brain prostaglandin H synthase activity and oxidative damage in mice with encephalitis.

Valyi-Nagy T, Sidell KR, Marnett LJ, Roberts LJ 2nd, Dermody TS, Morrow JD, Montine TJ. Valyi-Nagy T, et al. Among authors: morrow jd. J Neuropathol Exp Neurol. 1999 Dec;58(12):1269-75. doi: 10.1097/00005072-199912000-00008. J Neuropathol Exp Neurol. 1999. PMID: 10604752

10

Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase.

Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, Morrow JD. Marnett LJ, et al. Among authors: morrow jd. J Biol Chem. 2000 May 5;275(18):13427-30. doi: 10.1074/jbc.275.18.13427. J Biol Chem. 2000. PMID: 10788454 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters